Immunome, Inc. (IMNM)

USD 11.11

(-7.57%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 14.01 Million - - - - -
Cost of Revenue 22.92 Million 631 Thousand 755 Thousand 755 Thousand 615 Thousand 521 Thousand
Gross Profit -8.9 Million -631 Thousand -755 Thousand -755 Thousand -615 Thousand -521 Thousand
Operating Expenses 122.82 Million 36.9 Million 25.2 Million 12.26 Million 10.34 Million 7.74 Million
Selling, General and Administrative Expenses 19.65 Million 13.62 Million 11.09 Million 4.77 Million 1.52 Million 866 Thousand
Research and Development Expenses 80.8 Million 23.27 Million 14.11 Million 7.48 Million 8.82 Million 6.87 Million
Other Expenses 23.08 Million - 503 Thousand - - -
Cost and Expenses 123.54 Million 36.9 Million 25.2 Million 12.26 Million 10.34 Million 7.74 Million
Operating Income -109.53 Million -36.9 Million -25.2 Million -12.26 Million -10.34 Million -7.74 Million
Interest Expense - 5000.00 10 Thousand 38 Thousand 106 Thousand 141 Thousand
Income Tax Expense - 617 Thousand -242 Thousand -717 Thousand 106 Thousand 39 Thousand
Earnings before Tax -106.8 Million -36.89 Million -24.71 Million -17.83 Million -10.44 Million -7.84 Million
Net Income -106.8 Million -37.51 Million -24.46 Million -17.12 Million -10.55 Million -7.84 Million
Earnings Per Share Basic -5.38 -3.09 -2.12 -1.69 -1.84 -7.18
Earnings Per Share Diluted -5.38 -3.09 -2.12 -1.69 -1.84 -7.18
Weighted Average Shares Outstanding 19.84 Million 12.12 Million 11.53 Million 10.11 Million 5.74 Million 1.09 Million
Weighted Average Shares Outstanding (Diluted) 19.84 Million 12.12 Million 11.53 Million 10.11 Million 5.74 Million 1.09 Million
Gross Margin -0.64 - - - - -
EBIT Margin -2.02 - - - - -
Profit Margin -7.62 - - - - -
EBITDA -28.27 Million -36.26 Million -23.94 Million -17.04 Million -9.72 Million -7.18 Million
Earnings Before Tax Margin -7.81 - - - - -

Income Statement Charts